Quarterly report · Q3
4574.TEDINET S100S6X1
Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.4bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥5.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥444m | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | −¥2.8bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥589m | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥3.4bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.9bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥537m | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥3.2bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥562m | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥3.2bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥562m | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥3.2bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥15.8bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥16.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.0bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.8bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥9.8bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.1bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-12.09 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.98 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-112.26 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-72.97 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.8 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 61.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-09-30 | −¥738m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥724m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥724m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥643m |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥4m |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥4m |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥17m |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥3.7bn |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥3.7bn |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥955m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-09-30 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-09-30 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-09-30 | ¥293m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥893m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥976m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥976m |
| jpcrp040300-q3r_E22560-000Infection Control Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.8bn |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q3r_E22560-000Other Business Linesreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥14m |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E22560-000Pharmaceuticals Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥42m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-09-30 | −¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 365
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)溝 静太 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)塚本 健 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 3389000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 4417000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5040000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -2898000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -589000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -3352000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -3182000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -562000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -4895000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -3021000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -318000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -4796000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 9819000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 9763000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 8044000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 16474000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 15812000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 15046000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -72.97 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -12.09 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -112.26 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.596 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.617 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.535 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -8.80 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -0.98 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 50036900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 50236900 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 50036900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 50236900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 487100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 47728200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 477282 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 21600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 48236900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 477282 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 487100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |